Literature DB >> 15290204

The role of imaging in urinary tract infections.

Truls E Bjerklund Johansen1.   

Abstract

The aim of imaging in urinary tract infections (UTI) is to detect conditions that must be corrected to avoid imminent deterioration of kidney function, or to prevent recurrent infections and long-term kidney damage. The most threatening conditions are obstruction of an infected upper tract and abscesses of the genitourinary system. An image-guided percutaneous drainage can be lifesaving. The role of imaging in small children with UTI is controversial in terms of the importance of anatomical and functional disorders in relation to the preventive measures to be taken. In newborns identified with hydronephrosis during pregnancy or by neonatal screening, vesicoureteral reflux (VUR) and renal scarring are congenital and not caused by infection. Most of these patients are males and the VUR is of a higher grade than VUR detected in girls after the first UTI. Imaging in children with UTI should only be ordered after a thorough evaluation of the risk of renal damage and the benefits of preventive measures. In adult females, no imaging is necessary in cystitis, while ultrasonography and plain films are recommended in acute pyelonephritis. Since uncomplicated UTI in men is rare, diagnostic imaging should be started early to rule out complicating factors in the urinary tract. In prostatitis, vesiculitis, epididymitis and orchitis the role of imaging is to rule out abscess formation and testicular malignancies.

Entities:  

Mesh:

Year:  2004        PMID: 15290204     DOI: 10.1007/s00345-004-0414-z

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Primary and acquired renal scarring in boys and girls with urinary tract infection.

Authors:  M Wennerström; S Hansson; U Jodal; E Stokland
Journal:  J Pediatr       Date:  2000-01       Impact factor: 4.406

2.  [Imaging of acute urinary infections in adults. Radiologic findings and strategy for imaging procedures].

Authors:  M Bléry; J Tasu; L Rocher; Y Rondeau; A Miquel
Journal:  J Radiol       Date:  2000-09

3.  [Pre- and postpartum ultrasound examinations for diagnosis of urogenital abnormalities].

Authors:  K Hohenfellner; S Seemayer; G Stolz; W Mannhardt; P Habermehl; M Knuf; A Queisser-Luft
Journal:  Klin Padiatr       Date:  2000 Nov-Dec       Impact factor: 1.349

4.  An audit of RCP guidelines on DMSA scanning after urinary tract infection.

Authors:  P V Deshpande; K V Jones
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

5.  Diuretic MAG3 scintigraphy (F0) in acute pyelonephritis: regional parenchymal dysfunction and comparison with DMSA.

Authors:  G N Sfakianakis; F Cavagnaro; G Zilleruelo; C Abitbol; B Montane; M Georgiou; S Ezuddin; W Mallin; E Sfakianakis; J Strauss
Journal:  J Nucl Med       Date:  2000-12       Impact factor: 10.057

6.  Risk assessment of renal cortical scarring with urinary tract infection by clinical features and ultrasonography.

Authors:  M T Christian; J H McColl; J R MacKenzie; T J Beattie
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

7.  Primary vesicoureteric reflux and renal damage in the first year of life.

Authors:  G Lama; M Russo; E De Rosa; L Mansi; A Piscitelli; I Luongo; M Esposito Salsano
Journal:  Pediatr Nephrol       Date:  2000-12       Impact factor: 3.714

8.  The initial renal ultrasound examination in children with urinary tract infection: the prevalence of dilated uropathy has decreased.

Authors:  M J Gelfand; L L Barr; O Abunku
Journal:  Pediatr Radiol       Date:  2000-10

9.  UTI: diagnosis and evaluation in symptomatic pediatric patients.

Authors:  F J Heldrich; M A Barone; E Spiegler
Journal:  Clin Pediatr (Phila)       Date:  2000-08       Impact factor: 1.168

10.  Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age.

Authors:  S Mårild; U Jodal
Journal:  Acta Paediatr       Date:  1998-05       Impact factor: 2.299

View more
  7 in total

1.  Dynamic magnetic resonance imaging in acute pyelonephritis.

Authors:  M C Martina; P P Campanino; F Caraffo; C Marcuccio; F Gunetti; L Colla; M C Cassinis; G Gandini
Journal:  Radiol Med       Date:  2009-11-09       Impact factor: 3.469

Review 2.  Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder.

Authors:  C F Heyns
Journal:  World J Urol       Date:  2011-07-01       Impact factor: 4.226

3.  Diffusion-weighted imaging and apparent diffusion coefficient values versus contrast-enhanced MR imaging in the identification and characterisation of acute pyelonephritis.

Authors:  Riccardo Faletti; Maria Carla Cassinis; Paolo Fonio; Angela Grasso; Giacomo Battisti; Laura Bergamasco; Giovanni Gandini
Journal:  Eur Radiol       Date:  2013-07-26       Impact factor: 5.315

4.  Diffusion-weighted magnetic resonance imaging: new perspectives in the diagnostic pathway of non-complicated acute pyelonephritis.

Authors:  Agostino De Pascale; Giorgina Barbara Piccoli; Sandro Massimo Priola; Daniela Rognone; Valentina Consiglio; Irene Garetto; Laura Rizzo; Andrea Veltri
Journal:  Eur Radiol       Date:  2013-06-08       Impact factor: 5.315

5.  Diagnosing Acute Pyelonephritis with CT, Tc-DMSA SPECT, and Doppler Ultrasound: A Comparative Study.

Authors:  Je Mo Yoo; Jun Sung Koh; Chang Hee Han; Su Lim Lee; U-Syn Ha; Sung Hak Kang; Yun Seok Jung; Yong Seok Lee
Journal:  Korean J Urol       Date:  2010-04-20

6.  Radiological findings of sexual intercourse related emergency department admissions: a first overview.

Authors:  Carmen A Pfortmueller; Adrian C Schankath; Pasquale Mordasini; Jana Koetter; Roland Wiest; Aristomenis K Exadaktylos; Stefan Puig
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

7.  Clinical Usefulness of Unenhanced Computed Tomography in Patients with Acute Pyelonephritis.

Authors:  Anna Lee; Hyo-Cheol Kim; Sung Il Hwang; Ho Jun Chin; Ki Young Na; Dong-Wan Chae; Sejoong Kim
Journal:  J Korean Med Sci       Date:  2018-08-01       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.